Suggestions
Sanjay Rawat
Founder & CEO at RxBN & Company
Professional Background
Sanjay Rawat is a highly accomplished biopharmaceuticals formulation scientist, specializing in the development of innovative drug delivery systems and formulation strategies. With extensive experience in various aspects of biopharmaceutical formulation, Sanjay has made significant contributions to the field, particularly in the area of vaccine development and delivery. His expertise encompasses the formulation development of viral proteins, microneedle-based drug delivery systems, and polymer-based drug delivery solutions. A strong proponent of advancing scientific research and innovation, Sanjay Rawat’s work reflects a deep commitment to improving patient outcomes through the application of cutting-edge technologies.
Throughout his career, Sanjay has consistently engaged in process scale-up and cGMP manufacturing, ensuring that his developments meet rigorous quality standards. His proficiency in employing Design of Experiments (DOE) to drug formulations and processes aligns with the FDA’s Quality by Design (QbD) requirements, highlighting his dedication to regulatory compliance and product safety. He has played a pivotal role in various projects involving stability analysis in protein formulation and delivery systems, and he is adept at nanocrystal preparation technology for proteins, solid-state characterization, and optimization of preformulation processes.
Education and Achievements
Sanjay Rawat's academic qualifications reflect his stellar commitment to advancing knowledge in biopharmaceutical sciences. He holds a PhD in Biotechnology & Bioengineering from the renowned CSIR-Institute of Himalayan Bioresource Technology, where he developed a solid foundation in advanced biotechnological applications that serve as the cornerstone of his professional pursuits. He further honed his expertise in biopharmaceuticals drug delivery development through a Doctor of Philosophy (Ph.D.) program at the Institute of Microbial Technology (IMTECH-CSIR), showcasing his dedication to research excellence.
His journey in pharmaceutical biotechnology began with an Engineer's Degree (M.Tech.) from the National Institute of Pharmaceutical Education and Research, equipping him with the skills and knowledge necessary for innovative drug formulation. Sanjay also completed his Bachelor's Degree (B.Pharma.) in Pharmaceutical Sciences at Motivational Pathway, laying the groundwork for his future career in pharmaceuticals. Additionally, he furthered his studies at esteemed institutions such as Emory University and the Georgia Institute of Technology, which expanded his knowledge and research acumen.
Career Trajectory
Sanjay’s professional journey has been marked by a series of significant roles in both academic and industrial sectors, providing him with a diverse range of experiences. He served as the Founder and CEO at RxBN & Company, where he led initiatives in biopharmaceutical innovation and contributed to developing proprietary drug delivery technologies. His entrepreneurial spirit and vision were instrumental in establishing the company’s objectives and fostering a culture of scientific discovery.
As a self-employed consultant, Sanjay provided expert advice to various pharmaceutical and biotechnology firms, helping them navigate the complexities of biopharmaceutical development and formulation processes. His past experiences include serving as a Postdoctoral Fellow at the Georgia Cancer Center for Excellence at Grady Hospital and Morehouse School of Medicine, where he collaborated on innovative cancer therapeutics and enhanced drug delivery strategies.
Sanjay also held prestigious positions as a Postdoctoral Associate at Georgia Institute of Technology and Emory School of Medicine, contributing to interdisciplinary research projects aimed at solving pressing challenges in drug delivery and formulation. His keen insights allowed him to bridge the gap between academic research and practical application, positioning him as a vital asset in all collaborative endeavors.
In the academic realm, Sanjay has imparted his extensive knowledge as a lecturer at Delhi Paramedicals and Management Institute (DPMI) and the Pranveer Singh Group of Institutes, sharing his experience with future generations of pharmaceutical professionals. As a Research Associate at the Institute of Microbial Technology, he contributed to valuable research initiatives that have had lasting implications in the biopharmaceutical field.
Notable Achievements
Sanjay Rawat's career is characterized by a multitude of notable achievements that have positioned him as a leader in biopharmaceuticals. His innovative work with polymer-based drug delivery systems, particularly the use of nanoparticles and microspheres, has contributed to advancements in targeted drug delivery mechanisms, thereby enhancing therapeutic efficacy. In addition, his pioneering initiatives in developing microneedle-based technologies have opened new avenues for pain-free and efficient drug administration.
His research interests extend into stability analysis and nanocrystal preparation technologies for proteins, areas in which he has published numerous papers and presented at international conferences. This breadth of research showcases Sanjay's role as a thought leader in next-generation drug formulation and highlights his unwavering commitment to improving healthcare outcomes.
In summary, Sanjay Rawat’s professional profile not only demonstrates an impressive blend of practical expertise and academic prowess but also emphasizes his dedication to pioneering advancements in biopharmaceutical formulation and drug delivery systems. His trajectory indicates a promising future in enhancing medicinal therapies and contributing to improved lives through innovative pharmaceutical solutions.